These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21178385)

  • 21. Genistein sensitizes hepatic insulin signaling and modulates lipid regulatory genes through p70 ribosomal S6 kinase-1 inhibition in high-fat-high-fructose diet-fed mice.
    Arunkumar E; Karthik D; Anuradha CV
    Pharm Biol; 2013 Jul; 51(7):815-24. PubMed ID: 23627466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raw vegetable food containing high cyclo (his-pro) improved insulin sensitivity and body weight control.
    Song MK; Rosenthal MJ; Song AM; Yang H; Ao Y; Yamaguchi DT
    Metabolism; 2005 Nov; 54(11):1480-9. PubMed ID: 16253637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
    Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
    J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of 11beta-hydroxysteroid dehydrogenase inhibitor on body weight and glucose tolerance in Sprague-Dawley rats fed with a high-fat diet.
    Liu ZJ; Bai J; Wang YC; Yan D; Wang XX
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Jun; 9(3):183-7. PubMed ID: 17582250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicology and carcinogenesis studies of 3,3',4,4'-tetrachloroazobenzene (TCAB) (CAS No. 14047-09-7) in Harlan Sprague-Dawley rats and B6C3F1 mice (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2010 Nov; (558):1-206. PubMed ID: 21383777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures.
    Mack CM; Moore CX; Jodka CM; Bhavsar S; Wilson JK; Hoyt JA; Roan JL; Vu C; Laugero KD; Parkes DG; Young AA
    Int J Obes (Lond); 2006 Sep; 30(9):1332-40. PubMed ID: 16534527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
    Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV
    Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue-specific regulation of S6K1 by insulin in chickens divergently selected for growth.
    Duchêne S; Audouin E; Berri C; Dupont J; Tesseraud S
    Gen Comp Endocrinol; 2008 Mar; 156(1):190-8. PubMed ID: 18237733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis.
    Colombo M; Kruhoeffer M; Gregersen S; Agger A; Jeppesen P; Oerntoft T; Hermansen K
    Metabolism; 2006 Jan; 55(1):43-52. PubMed ID: 16324918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat.
    Velkoska E; Warner FJ; Cole TJ; Smith I; Morris MJ
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):49-55. PubMed ID: 19361967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exercise training attenuates lipectomy-induced impaired glucose tolerance in rats.
    Coelho DF; Gualano B; Artioli GG; Roschel H; Amano M; Benatti FB; Fernandes T; Bueno CR; Câmara NO; Lancha AH
    Endocr Regul; 2009 Jul; 43(3):107-16. PubMed ID: 19817505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
    Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
    Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of a small molecule inhibitor of c-Jun kinase.
    Cho H; Black SC; Looper D; Shi M; Kelly-Sullivan D; Timofeevski S; Siegel K; Yu XH; McDonnell SR; Chen P; Yie J; Ogilvie KM; Fraser J; Briscoe CP
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1142-51. PubMed ID: 18728225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of combined olmesartan and pravastatin on glucose intolerance and cardiovascular remodeling in a metabolic-syndrome model.
    Mizukawa M; Ohmori K; Obayashi A; Ishihara Y; Yoshida J; Noma T; Yukiiri K; Kosaka H; Kohno M
    Hypertens Res; 2009 Jul; 32(7):617-24. PubMed ID: 19461650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1.
    Um SH; D'Alessio D; Thomas G
    Cell Metab; 2006 Jun; 3(6):393-402. PubMed ID: 16753575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rose hip exerts antidiabetic effects via a mechanism involving downregulation of the hepatic lipogenic program.
    Andersson U; Henriksson E; Ström K; Alenfall J; Göransson O; Holm C
    Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E111-21. PubMed ID: 20959531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue.
    Houde VP; Brûlé S; Festuccia WT; Blanchard PG; Bellmann K; Deshaies Y; Marette A
    Diabetes; 2010 Jun; 59(6):1338-48. PubMed ID: 20299475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of mitochondrial complex 1 by the S6K1 inhibitor PF-4708671 partly contributes to its glucose metabolic effects in muscle and liver cells.
    Shum M; Houde VP; Bellemare V; Junges Moreira R; Bellmann K; St-Pierre P; Viollet B; Foretz M; Marette A
    J Biol Chem; 2019 Aug; 294(32):12250-12260. PubMed ID: 31243102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial metabolic effects of CB1R anti-sense oligonucleotide treatment in diet-induced obese AKR/J mice.
    Tang Y; Ho G; Li Y; Hall MA; Hills RL; Black SC; Liang Y; Demarest KT
    PLoS One; 2012; 7(8):e42134. PubMed ID: 22870290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.